Results indicate a need for providers to ask depressed patients about their marijuana use.
A rise in overdose deaths is associated with overprescribing of opioid analgesic medications.
Fewer people believe marijuana is harmful.
Δ9-Tetrahydrocannabinol (THC) is the main psychoactive chemical ingredient in cannabis.
The report also sheds light on the most significant predictors of substance abuse.
The increased use of synthetic cannabinoids presents a serious public health threat.
Alterations in reward processing may increase users' risk of continued drug use and subsequent addiction.
Chronic and severe cannabis-dependence is associated with deficits in striatal dopamine release.
Marijuana use is associated with development of various neuropsychiatric conditions such as schizophrenia, anxiety, and depression.
Tetrahydrocannabinol (THC) is the main active chemical ingredient found in cannabis and is a potent cannabinoid receptor (CB)-1 agonist.
Prolonged cannabis use is a risk factor for periodontal disease.
Study links heavy cannabis use in male teens to increased mortality by age 60.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- FOSTA-SESTA Threatens Sex Worker Livelihoods: What Mental Health Providers Should Know
- Strong Social Networks May Mitigate the Effects of Childhood Adversity
- Sodium Valproate May Lower Amygdala Volume in Pediatric Bipolar Disorder
- False Positives in Mood Disorders Questionnaire Screening for Bipolar Disorder
- Suicidal Behavior More Likely in Depression, Bipolar Disorder With Mixed Features
- Medical Clearance of Psych Patients in the ED: Consensus Recommendations
- From Abused Child to Serial Killer: Investigating Nature vs Nurture in Methods of Murder
- Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach
- Dialectical Behavior Therapy Effective in Reducing Suicide Attempts, Self-Harm in Adolescents
- Novel Parent-Child Interaction Therapy Targets Preschool-Aged Depression
- Challenges Psychiatrists Face in Treating Patients with Bipolar Disorder
- Parent-Child Interaction Therapy May Improve Depression and Emotional Function
- Identifying Problems of Functioning in Schizophrenia Informs Approaches to Intervention
- Visual Hallucinations in Dementia and Parkinson Disease: Assessment of Patient, Caregiver Experiences
- FDA Outlines Plan for Increasing Nonprescription Drug Availability